TRIAMTERENE CAPSULES

TRIAMTERENE CAPSULES was reported 7179 times

TRIAMTERENE CAPSULES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOOT PROSTHESIS USER 5 0.3333
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 19 0.0179
2 REBOUND ACID HYPERSECRETION 54 0.0178
3 CRYSTAL NEPHROPATHY 9 0.0152
4 NEPHROGENIC ANAEMIA 57 0.0123
5 LICHENIFICATION 5 0.0122
6 HYPERPARATHYROIDISM SECONDARY 27 0.0108
7 NERVE ROOT COMPRESSION 5 0.0086
8 ANAEMIA OF CHRONIC DISEASE 7 0.0077
9 HYPOCHLORAEMIA 9 0.0077
10 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
11 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
12 PSYCHOLOGICAL TRAUMA 54 0.0063
13 EXCESSIVE GRANULATION TISSUE 5 0.0062
14 HAIR DISORDER 51 0.0062
15 CHRONIC KIDNEY DISEASE 469 0.0062
16 DIABETIC NEUROPATHY 30 0.0061
17 INNER EAR DISORDER 6 0.0056
18 ANOGENITAL WARTS 5 0.0056
19 LEFT ATRIAL DILATATION 7 0.0055
20 LUMBAR RADICULOPATHY 6 0.0052
21 END STAGE RENAL DISEASE 92 0.0050
22 HYPERTENSIVE HEART DISEASE 9 0.0048
23 HAIR TEXTURE ABNORMAL 62 0.0046
24 HAIR COLOUR CHANGES 57 0.0046
25 CARDIOACTIVE DRUG LEVEL INCREASED 6 0.0046
26 MEGACOLON 7 0.0045
27 BENIGN NEOPLASM 5 0.0044
28 MADAROSIS 46 0.0040
29 SPINAL COLUMN STENOSIS 18 0.0038
30 METABOLIC ALKALOSIS 6 0.0037
31 TUBULOINTERSTITIAL NEPHRITIS 68 0.0036
32 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
33 ESSENTIAL HYPERTENSION 6 0.0033
34 SPINAL OSTEOARTHRITIS 28 0.0032
35 ILEUS PARALYTIC 14 0.0031
36 COLONIC POLYP 5 0.0030
37 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
38 PLANTAR FASCIITIS 10 0.0030
39 FOAMING AT MOUTH 6 0.0030
40 SHOULDER ARTHROPLASTY 8 0.0030
41 HEPATIC CYST 10 0.0029
42 POLYCYTHAEMIA 6 0.0029
43 ELECTRIC SHOCK SENSATION 8 0.0029
44 HEART INJURY 7 0.0028
45 PHARYNGEAL DISORDER 8 0.0028
46 PERIODONTITIS 6 0.0028
47 HYPERTONIC BLADDER 8 0.0028
48 LUMBAR SPINAL STENOSIS 8 0.0027
49 AORTIC ARTERIOSCLEROSIS 7 0.0027
50 MULTIPLE INJURIES 17 0.0027
51 THERAPEUTIC AGENT TOXICITY 9 0.0027
52 RENAL INJURY 80 0.0027
53 FEAR OF DEATH 6 0.0027
54 RADICULOPATHY 7 0.0027
55 ROTATOR CUFF SYNDROME 33 0.0026
56 EARLY SATIETY 5 0.0026
57 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
58 HAEMORRHAGIC ANAEMIA 11 0.0025
59 PNEUMONIA ASPIRATION 62 0.0025
60 MITRAL VALVE INCOMPETENCE 28 0.0025
61 RENAL FAILURE 325 0.0024
62 ECONOMIC PROBLEM 37 0.0024
63 HYPERPARATHYROIDISM 5 0.0024
64 VENTRICULAR HYPERTROPHY 6 0.0024
65 TRICUSPID VALVE INCOMPETENCE 19 0.0024
66 NERVE COMPRESSION 22 0.0024
67 BLOOD POTASSIUM DECREASED 71 0.0024
68 HYPERLIPIDAEMIA 28 0.0023
69 BODY HEIGHT DECREASED 25 0.0023
70 GASTROOESOPHAGEAL REFLUX DISEASE 188 0.0023
71 CEREBROVASCULAR DISORDER 7 0.0023
72 HIATUS HERNIA 30 0.0023
73 VENTRICULAR DYSFUNCTION 6 0.0023
74 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
75 IMPAIRED QUALITY OF LIFE 33 0.0023
76 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
77 RENAL CYST 18 0.0023
78 SCOLIOSIS 14 0.0023
79 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
80 HAEMORRHAGIC DIATHESIS 8 0.0022
81 CANDIDIASIS 9 0.0022
82 NON-CARDIAC CHEST PAIN 7 0.0022
83 RHINALGIA 6 0.0022
84 HYPERKERATOSIS 12 0.0022
85 ATELECTASIS 21 0.0022
86 OSTEOARTHRITIS 92 0.0022
87 PERIPHERAL VASCULAR DISORDER 11 0.0021
88 BUNDLE BRANCH BLOCK LEFT 9 0.0021
89 DIVERTICULUM 15 0.0021
90 FIBULA FRACTURE 6 0.0021
91 STRESS CARDIOMYOPATHY 12 0.0021
92 JOINT EFFUSION 14 0.0020
93 ACUTE KIDNEY INJURY 302 0.0020
94 RENAL TUBULAR NECROSIS 19 0.0019
95 TIBIA FRACTURE 9 0.0019
96 POLYARTHRITIS 10 0.0019
97 FOOT DEFORMITY 21 0.0019
98 ANIMAL BITE 5 0.0019
99 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
100 CHONDROPATHY 5 0.0018
101 LYMPHOPENIA 26 0.0018
102 LIP BLISTER 5 0.0018
103 TONGUE DISCOLOURATION 8 0.0018
104 CORONARY ARTERY OCCLUSION 25 0.0018
105 BLOOD SODIUM DECREASED 34 0.0018
106 JOINT RANGE OF MOTION DECREASED 24 0.0018
107 MENISCUS INJURY 11 0.0018
108 ANAL HAEMORRHAGE 5 0.0018
109 ULCER HAEMORRHAGE 12 0.0018
110 NECK MASS 5 0.0018
111 HYPERPHAGIA 7 0.0018
112 DIFFICULTY IN WALKING 6 0.0017
113 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
114 AORTIC STENOSIS 6 0.0017
115 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
116 AORTIC ANEURYSM 13 0.0017
117 NECK INJURY 5 0.0017
118 ARTERIOSCLEROSIS 16 0.0017
119 RENAL FAILURE CHRONIC 13 0.0017
120 FIBRIN D DIMER INCREASED 6 0.0017
121 FOOT FRACTURE 32 0.0017
122 SINUS HEADACHE 10 0.0017
123 CREPITATIONS 5 0.0017
124 MULTIPLE ALLERGIES 13 0.0017
125 BURSITIS 20 0.0016
126 AORTIC VALVE INCOMPETENCE 7 0.0016
127 CAROTID ARTERY OCCLUSION 6 0.0016
128 UTERINE LEIOMYOMA 12 0.0016
129 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
130 INTRACARDIAC THROMBUS 5 0.0016
131 INFLAMMATORY MARKER INCREASED 8 0.0016
132 CHRONIC SINUSITIS 6 0.0016
133 ABDOMINAL ADHESIONS 5 0.0016
134 PARANASAL SINUS HYPERSECRETION 6 0.0016
135 BILE DUCT STONE 5 0.0016
136 CUSHINGOID 5 0.0016
137 IRON DEFICIENCY 7 0.0016
138 HAND FRACTURE 11 0.0016
139 LOOSE TOOTH 5 0.0016
140 CORONARY ARTERY DISEASE 46 0.0015
141 SYNOVIAL CYST 7 0.0015
142 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
143 APPETITE DISORDER 10 0.0015
144 OESOPHAGEAL CANDIDIASIS 6 0.0015
145 CEREBRAL ATROPHY 6 0.0015
146 GOUT 27 0.0015
147 ATRIAL FLUTTER 12 0.0015
148 MUSCLE STRAIN 13 0.0015
149 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
150 CARPAL TUNNEL SYNDROME 21 0.0015
151 CHOLECYSTITIS CHRONIC 10 0.0015
152 BLINDNESS TRANSIENT 11 0.0015
153 SKIN TIGHTNESS 7 0.0015
154 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
155 TRIGGER FINGER 6 0.0015
156 GOITRE 6 0.0015
157 GALLBLADDER DISORDER 26 0.0015
158 SPINAL COMPRESSION FRACTURE 12 0.0014
159 HYPERCHOLESTEROLAEMIA 14 0.0014
160 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
161 BONE DISORDER 26 0.0014
162 EXPIRED DRUG ADMINISTERED 7 0.0014
163 UTERINE HAEMORRHAGE 6 0.0014
164 ANHEDONIA 37 0.0014
165 INTERVERTEBRAL DISC DISORDER 6 0.0014
166 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
167 FRUSTRATION 5 0.0014
168 PHOTOSENSITIVITY REACTION 23 0.0014
169 CORONARY ARTERY STENOSIS 7 0.0014
170 BLOOD MAGNESIUM DECREASED 12 0.0014
171 FACIAL BONES FRACTURE 5 0.0014
172 CARDIAC MURMUR 12 0.0014
173 ANGINA UNSTABLE 9 0.0014
174 OSTEOPENIA 21 0.0014
175 CARDIOMEGALY 17 0.0014
176 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
177 DIVERTICULUM INTESTINAL 6 0.0014
178 ANKLE FRACTURE 21 0.0014
179 RHINITIS ALLERGIC 6 0.0013
180 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
181 VITAMIN D DEFICIENCY 13 0.0013
182 HYPERSOMNIA 38 0.0013
183 JOINT DISLOCATION 14 0.0013
184 COMA 63 0.0013
185 VITREOUS FLOATERS 13 0.0013
186 LOCAL SWELLING 23 0.0013
187 MYOCARDIAL ISCHAEMIA 15 0.0013
188 INGUINAL HERNIA 8 0.0013
189 LIGAMENT SPRAIN 13 0.0013
190 EXOSTOSIS 12 0.0013
191 ECCHYMOSIS 9 0.0013
192 INJECTION SITE PAPULE 6 0.0013
193 COMPRESSION FRACTURE 7 0.0013
194 GINGIVAL DISORDER 5 0.0013
195 LARGE INTESTINE POLYP 9 0.0013
196 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
197 BRUXISM 7 0.0013
198 PIGMENTATION DISORDER 8 0.0013
199 VITAMIN D DECREASED 11 0.0013
200 NEPHROPATHY 12 0.0013
201 HAEMORRHOIDS 25 0.0013
202 MUSCULOSKELETAL DISCOMFORT 22 0.0013
203 TYPE 2 DIABETES MELLITUS 43 0.0013
204 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
205 VENTRICULAR TACHYCARDIA 21 0.0013
206 DYSPHONIA 74 0.0013
207 ALOPECIA 245 0.0012
208 FINGER DEFORMITY 6 0.0012
209 DECUBITUS ULCER 10 0.0012
210 CONTUSION 118 0.0012
211 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
212 JOINT INJURY 26 0.0012
213 TENDON RUPTURE 15 0.0012
214 FOOT OPERATION 6 0.0012
215 ANEURYSM 6 0.0012
216 SLEEP APNOEA SYNDROME 23 0.0012
217 HYPERTRIGLYCERIDAEMIA 7 0.0012
218 INCREASED TENDENCY TO BRUISE 11 0.0012
219 ERYSIPELAS 6 0.0012
220 PAROSMIA 9 0.0012
221 SCIATICA 19 0.0012
222 OSTEOPOROSIS 49 0.0012
223 HALLUCINATIONS, MIXED 5 0.0012
224 CATARACT OPERATION 7 0.0012
225 HIP ARTHROPLASTY 18 0.0012
226 FUNGAL INFECTION 39 0.0012
227 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
228 PERIPHERAL COLDNESS 16 0.0012
229 PAIN IN JAW 33 0.0012
230 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
231 VARICOSE VEIN 6 0.0012
232 STOMACH DISCOMFORT 6 0.0012
233 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
234 HEPATIC LESION 5 0.0012
235 FAILURE TO THRIVE 6 0.0012
236 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
237 TOOTH INFECTION 15 0.0011
238 BRONCHITIS 84 0.0011
239 LIGAMENT RUPTURE 5 0.0011
240 RENAL FAILURE ACUTE 48 0.0011
241 PRE-EXISTING CONDITION IMPROVED 7 0.0011
242 OVERWEIGHT 6 0.0011
243 BLADDER DISORDER 11 0.0011
244 MUSCULOSKELETAL PAIN 58 0.0011
245 HEART RATE IRREGULAR 25 0.0011
246 TENDONITIS 17 0.0011
247 ORAL DISORDER 8 0.0011
248 OEDEMA PERIPHERAL 133 0.0011
249 TOOTH FRACTURE 12 0.0011
250 ABNORMAL DREAMS 30 0.0011
251 DENTAL CARIES 12 0.0011
252 EMBOLISM 9 0.0011
253 HYPOKALAEMIA 50 0.0011
254 CARDIAC FLUTTER 7 0.0011
255 NERVE INJURY 12 0.0011
256 SLUGGISHNESS 11 0.0011
257 HEART RATE ABNORMAL 6 0.0011
258 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
259 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 56 0.0011
260 GASTRITIS EROSIVE 5 0.0011
261 LIMB DISCOMFORT 33 0.0011
262 GASTRITIS 28 0.0011
263 LACERATION 10 0.0011
264 DYSGRAPHIA 7 0.0011
265 PERONEAL NERVE PALSY 6 0.0011
266 MUSCLE TIGHTNESS 17 0.0010
267 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
268 SKIN ATROPHY 6 0.0010
269 FEAR 28 0.0010
270 FAECAL INCONTINENCE 5 0.0010
271 SINUS BRADYCARDIA 10 0.0010
272 MUSCULOSKELETAL CHEST PAIN 16 0.0010
273 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
274 RALES 6 0.0010
275 FIBROMYALGIA 25 0.0010
276 ATRIAL FIBRILLATION 100 0.0010
277 HYPOVOLAEMIA 6 0.0010
278 LUNG INFILTRATION 9 0.0010
279 DECREASED INTEREST 6 0.0010
280 UNDERDOSE 74 0.0010
281 ANGINA PECTORIS 29 0.0010
282 BACK INJURY 11 0.0010
283 HAIR GROWTH ABNORMAL 7 0.0010
284 NASAL DISCOMFORT 8 0.0010
285 BLOOD ALBUMIN DECREASED 8 0.0010
286 MYOCLONUS 12 0.0010
287 ODYNOPHAGIA 6 0.0010
288 HYPERNATRAEMIA 5 0.0010
289 APHONIA 14 0.0010
290 CARDIAC FAILURE CONGESTIVE 80 0.0010
291 BALANCE DISORDER 86 0.0010
292 BLOOD COUNT ABNORMAL 15 0.0010
293 BLOOD CHOLESTEROL INCREASED 46 0.0010
294 DYSLIPIDAEMIA 5 0.0010
295 DRY THROAT 10 0.0010
296 ORAL PAIN 22 0.0010
297 HEAD INJURY 31 0.0010
298 EAR PAIN 19 0.0010
299 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
300 HYPONATRAEMIA 55 0.0010
301 DYSPEPSIA 96 0.0010
302 FEMORAL NECK FRACTURE 5 0.0010
303 DRY MOUTH 79 0.0010
304 VISUAL FIELD DEFECT 7 0.0010
305 NECK PAIN 54 0.0010
306 MIDDLE INSOMNIA 18 0.0010
307 BASAL CELL CARCINOMA 15 0.0010
308 HAEMATOCRIT DECREASED 19 0.0010
309 SQUAMOUS CELL CARCINOMA 9 0.0010
310 INCONTINENCE 10 0.0009
311 PRESYNCOPE 23 0.0009
312 ARTHRITIS 74 0.0009
313 TOOTHACHE 17 0.0009
314 OSTEOMYELITIS 17 0.0009
315 POLLAKIURIA 39 0.0009
316 RESTLESS LEGS SYNDROME 17 0.0009
317 GLAUCOMA 18 0.0009
318 ANOREXIA 12 0.0009
319 ERUCTATION 18 0.0009
320 POOR QUALITY SLEEP 20 0.0009
321 GINGIVITIS 5 0.0009
322 POOR QUALITY DRUG ADMINISTERED 6 0.0009
323 INCOHERENT 6 0.0009
324 CHEILITIS 5 0.0009
325 HYSTERECTOMY 8 0.0009
326 CHOLELITHIASIS 30 0.0009
327 BOWEL MOVEMENT IRREGULARITY 7 0.0009
328 BACK PAIN 212 0.0009
329 BLOOD CALCIUM INCREASED 8 0.0009
330 THYROID DISORDER 14 0.0009
331 KNEE ARTHROPLASTY 19 0.0009
332 BLOOD UREA INCREASED 15 0.0009
333 FULL BLOOD COUNT DECREASED 18 0.0009
334 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
335 RETCHING 19 0.0009
336 NEPHROPATHY TOXIC 10 0.0009
337 BLOOD CALCIUM DECREASED 10 0.0009
338 POSTOPERATIVE WOUND INFECTION 6 0.0009
339 FLUSHING 90 0.0009
340 TOOTH ABSCESS 9 0.0009
341 INJURY 62 0.0009
342 AGEUSIA 22 0.0009
343 ABNORMAL LOSS OF WEIGHT 6 0.0009
344 RENAL DISORDER 41 0.0009
345 GENERALISED ERYTHEMA 5 0.0009
346 STAPHYLOCOCCAL INFECTION 29 0.0009
347 SCAB 10 0.0009
348 INTERNAL HAEMORRHAGE 10 0.0009
349 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
350 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
351 CORONARY ARTERY BYPASS 5 0.0009
352 DIABETES MELLITUS 66 0.0009
353 FLATULENCE 49 0.0009
354 ARTHROPATHY 48 0.0009
355 HYPERVENTILATION 5 0.0009
356 DYSGEUSIA 64 0.0009
357 BACK DISORDER 14 0.0009
358 HEPATIC STEATOSIS 16 0.0009
359 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
360 EPISTAXIS 64 0.0009
361 MOUTH ULCERATION 18 0.0009
362 INCORRECT DRUG ADMINISTRATION DURATION 24 0.0009
363 JOINT SWELLING 103 0.0009
364 SINUS TACHYCARDIA 12 0.0008
365 PAIN IN EXTREMITY 249 0.0008
366 MUSCLE SPASMS 155 0.0008
367 DYSURIA 31 0.0008
368 COAGULOPATHY 14 0.0008
369 CARDIAC PACEMAKER INSERTION 5 0.0008
370 PERIPHERAL SWELLING 129 0.0008
371 SOMNOLENCE 167 0.0008
372 MENTAL STATUS CHANGES 23 0.0008
373 HERNIA 16 0.0008
374 RIB FRACTURE 17 0.0008
375 BREAST CANCER FEMALE 22 0.0008
376 INJECTION SITE NODULE 9 0.0008
377 PSEUDOMONAS INFECTION 7 0.0008
378 OBESITY 13 0.0008
379 CARDIOMYOPATHY 12 0.0008
380 BLOOD PRESSURE INCREASED 124 0.0008
381 GENERALISED OEDEMA 10 0.0008
382 FEELING DRUNK 6 0.0008
383 INSOMNIA 215 0.0008
384 GINGIVAL BLEEDING 11 0.0008
385 OLIGURIA 5 0.0008
386 DEPRESSION 183 0.0008
387 GLOSSODYNIA 18 0.0008
388 TOOTH EXTRACTION 10 0.0008
389 OCULAR DISCOMFORT 9 0.0008
390 WRONG TECHNIQUE IN DRUG USAGE PROCESS 29 0.0008
391 HYPOCALCAEMIA 15 0.0008
392 IMPAIRED DRIVING ABILITY 9 0.0008
393 MULTIPLE FRACTURES 13 0.0008
394 HYPOMAGNESAEMIA 11 0.0008
395 MICTURITION URGENCY 9 0.0008
396 ANXIETY 224 0.0008
397 BONE PAIN 46 0.0008
398 DEEP VEIN THROMBOSIS 51 0.0008
399 FACIAL PAIN 7 0.0008
400 LIPASE INCREASED 6 0.0008
401 NEOPLASM 9 0.0008
402 BLOOD TEST ABNORMAL 11 0.0008
403 GASTRIC HAEMORRHAGE 9 0.0008
404 HYPOAESTHESIA 117 0.0008
405 LIP SWELLING 26 0.0008
406 ACUTE MYOCARDIAL INFARCTION 23 0.0008
407 NIGHT SWEATS 25 0.0008
408 CONSTIPATION 169 0.0008
409 HYPERTENSION 164 0.0008
410 RHINORRHOEA 50 0.0008
411 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
412 APPLICATION SITE VESICLES 5 0.0008
413 VENTRICULAR EXTRASYSTOLES 8 0.0008
414 DYSPNOEA EXERTIONAL 29 0.0008
415 RED BLOOD CELL COUNT DECREASED 22 0.0008
416 ORAL HERPES 15 0.0008
417 HAEMORRHAGIC STROKE 6 0.0008
418 EMOTIONAL DISTRESS 93 0.0008
419 HEMIPARESIS 13 0.0008
420 JOINT STIFFNESS 20 0.0008
421 TINNITUS 35 0.0008
422 SCAR 13 0.0008
423 BLOOD IRON DECREASED 9 0.0008
424 IRON DEFICIENCY ANAEMIA 7 0.0008
425 GRAND MAL CONVULSION 7 0.0008
426 SNEEZING 17 0.0008
427 VISION BLURRED 104 0.0008
428 DEHYDRATION 101 0.0008
429 LIVER FUNCTION TEST ABNORMAL 22 0.0008
430 FLUID OVERLOAD 11 0.0008
431 ULCER 12 0.0008
432 FALL 251 0.0008
433 MACULAR DEGENERATION 9 0.0008
434 SINUSITIS 77 0.0008
435 WRIST FRACTURE 9 0.0008
436 BLOOD DISORDER 6 0.0007
437 DIARRHOEA HAEMORRHAGIC 7 0.0007
438 FLANK PAIN 7 0.0007
439 IRRITABLE BOWEL SYNDROME 16 0.0007
440 LABORATORY TEST ABNORMAL 22 0.0007
441 RECTAL HAEMORRHAGE 32 0.0007
442 RHINITIS 6 0.0007
443 FEELING ABNORMAL 178 0.0007
444 URINARY INCONTINENCE 22 0.0007
445 SKIN HAEMORRHAGE 11 0.0007
446 STOMATITIS 45 0.0007
447 DECREASED ACTIVITY 8 0.0007
448 ROAD TRAFFIC ACCIDENT 31 0.0007
449 MUSCLE DISORDER 6 0.0007
450 SINUS CONGESTION 10 0.0007
451 METASTASES TO LIVER 13 0.0007
452 PULMONARY MASS 11 0.0007
453 ARTHRALGIA 307 0.0007
454 FAECES DISCOLOURED 16 0.0007
455 POST PROCEDURAL INFECTION 6 0.0007
456 BLOOD URINE PRESENT 14 0.0007
457 GAIT DISTURBANCE 141 0.0007
458 GASTRIC ULCER 14 0.0007
459 SWOLLEN TONGUE 23 0.0007
460 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
461 CELLULITIS 37 0.0007
462 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
463 POLYURIA 6 0.0007
464 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
465 IMPAIRED HEALING 24 0.0007
466 HOT FLUSH 55 0.0007
467 CROHN'S DISEASE 5 0.0007
468 ONYCHOCLASIS 5 0.0007
469 ABDOMINAL PAIN UPPER 149 0.0007
470 VENTRICULAR FIBRILLATION 8 0.0007
471 DYSSTASIA 21 0.0007
472 OEDEMA 39 0.0007
473 SECRETION DISCHARGE 9 0.0007
474 HEART RATE INCREASED 71 0.0007
475 MOVEMENT DISORDER 23 0.0007
476 BURNING SENSATION 50 0.0007
477 BLISTER 40 0.0007
478 MUSCLE ATROPHY 9 0.0007
479 EYE INFECTION 8 0.0007
480 SINUS DISORDER 14 0.0007
481 HAEMATOCHEZIA 39 0.0007
482 MYALGIA 120 0.0007
483 NEUROPATHY PERIPHERAL 67 0.0007
484 PAIN 432 0.0007
485 OVARIAN CYST 7 0.0007
486 LIMB INJURY 19 0.0007
487 CYANOSIS 11 0.0007
488 NEURALGIA 17 0.0007
489 SPINAL FRACTURE 14 0.0007
490 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
491 PSORIASIS 91 0.0007
492 LETHARGY 40 0.0007
493 LACRIMATION INCREASED 21 0.0007
494 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
495 EMPHYSEMA 7 0.0007
496 PALPITATIONS 81 0.0007
497 OROPHARYNGEAL PAIN 64 0.0007
498 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
499 CEREBROVASCULAR ACCIDENT 117 0.0007
500 RENAL IMPAIRMENT 58 0.0007
501 NODULE 9 0.0007
502 SKIN DISORDER 23 0.0007
503 ORTHOSTATIC HYPOTENSION 12 0.0007
504 ABASIA 17 0.0007
505 WEIGHT INCREASED 154 0.0007
506 OSTEONECROSIS OF JAW 17 0.0007
507 BODY TEMPERATURE INCREASED 14 0.0007
508 ASTHENIA 258 0.0007
509 DIVERTICULITIS 19 0.0007
510 ORAL CANDIDIASIS 9 0.0007
511 PULMONARY CONGESTION 9 0.0007
512 FEELING JITTERY 13 0.0007
513 EAR DISCOMFORT 7 0.0007
514 MOUTH HAEMORRHAGE 5 0.0007
515 HAEMOPTYSIS 19 0.0007
516 WEIGHT DECREASED 190 0.0007
517 INCREASED APPETITE 13 0.0007
518 FEMUR FRACTURE 21 0.0007
519 DIZZINESS 338 0.0007
520 MUSCULAR WEAKNESS 77 0.0007
521 LOWER LIMB FRACTURE 13 0.0007
522 INTENTIONAL PRODUCT MISUSE 59 0.0007
523 PULMONARY EMBOLISM 64 0.0007
524 EYE SWELLING 25 0.0007
525 TENDERNESS 7 0.0007
526 ANAEMIA 128 0.0007
527 THROAT IRRITATION 30 0.0007
528 URINARY TRACT INFECTION 114 0.0007
529 ABDOMINAL DISCOMFORT 112 0.0007
530 CHOKING 13 0.0007
531 PSORIATIC ARTHROPATHY 27 0.0007
532 HYPOAESTHESIA ORAL 10 0.0007
533 APHASIA 20 0.0007
534 EXPIRED PRODUCT ADMINISTERED 22 0.0007
535 DRUG EFFECT INCOMPLETE 24 0.0007
536 CRYING 24 0.0007
537 MENTAL IMPAIRMENT 16 0.0007
538 COUGH 185 0.0007
539 CYSTITIS 21 0.0007
540 NOCTURIA 8 0.0007
541 BLOOD CREATININE INCREASED 43 0.0007
542 RASH MACULAR 23 0.0007
543 HYPOTHYROIDISM 21 0.0007
544 EATING DISORDER 14 0.0007
545 VERTIGO 40 0.0007
546 BLOOD PRESSURE ABNORMAL 13 0.0007
547 HIP FRACTURE 21 0.0007
548 RETINAL DETACHMENT 6 0.0007
549 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
550 ENCEPHALOPATHY 16 0.0007
551 SKIN CANCER 14 0.0006
552 DEAFNESS 17 0.0006
553 PHARYNGEAL OEDEMA 10 0.0006
554 DRUG EFFECT DECREASED 35 0.0006
555 FLUID RETENTION 33 0.0006
556 INJECTION SITE EXTRAVASATION 8 0.0006
557 ORAL DISCOMFORT 9 0.0006
558 PULMONARY OEDEMA 29 0.0006
559 PERSONALITY CHANGE 6 0.0006
560 PHARYNGITIS 8 0.0006
561 THINKING ABNORMAL 12 0.0006
562 DRY EYE 32 0.0006
563 TASTE DISORDER 13 0.0006
564 HEPATIC CIRRHOSIS 12 0.0006
565 MYOCARDIAL INFARCTION 111 0.0006
566 GASTROINTESTINAL PAIN 7 0.0006
567 FEELING HOT 39 0.0006
568 SEASONAL ALLERGY 9 0.0006
569 SPINAL DISORDER 6 0.0006
570 ABDOMINAL DISTENSION 66 0.0006
571 FURUNCLE 5 0.0006
572 PNEUMOTHORAX 10 0.0006
573 MUSCULOSKELETAL DISORDER 12 0.0006
574 SYNCOPE 63 0.0006
575 HYPERHIDROSIS 81 0.0006
576 INJECTION SITE IRRITATION 8 0.0006
577 THROAT TIGHTNESS 17 0.0006
578 MUSCULOSKELETAL STIFFNESS 55 0.0006
579 EYE IRRITATION 36 0.0006
580 DEPRESSED MOOD 33 0.0006
581 PULMONARY HYPERTENSION 13 0.0006
582 SKIN INFECTION 7 0.0006
583 VAGINAL HAEMORRHAGE 27 0.0006
584 EYE PAIN 35 0.0006
585 PRURITUS 238 0.0006
586 MYASTHENIA GRAVIS 5 0.0006
587 SKIN ULCER 16 0.0006
588 DIARRHOEA 399 0.0006
589 HAEMATOMA 16 0.0006
590 DECREASED APPETITE 143 0.0006
591 THIRST 11 0.0006
592 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
593 CHEST DISCOMFORT 63 0.0006
594 SKIN FISSURES 12 0.0006
595 PHARYNGEAL SWELLING 6 0.0006
596 HAEMATURIA 21 0.0006
597 CHOLECYSTECTOMY 7 0.0006
598 SKIN DISCOLOURATION 28 0.0006
599 GASTROENTERITIS VIRAL 11 0.0006
600 HYPERAESTHESIA 5 0.0006
601 NASOPHARYNGITIS 112 0.0006
602 DYSPNOEA 343 0.0006
603 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
604 PARAESTHESIA 95 0.0006
605 ACUTE CORONARY SYNDROME 5 0.0006
606 UPPER LIMB FRACTURE 12 0.0006
607 PRURITUS GENERALISED 13 0.0006
608 FATIGUE 468 0.0006
609 RHEUMATOID ARTHRITIS 68 0.0006
610 SPLENOMEGALY 7 0.0006
611 MALIGNANT MELANOMA 8 0.0006
612 QUALITY OF LIFE DECREASED 8 0.0006
613 UNEVALUABLE EVENT 45 0.0006
614 MELAENA 13 0.0006
615 DYSPHAGIA 56 0.0006
616 CHEST PAIN 109 0.0006
617 IMPAIRED GASTRIC EMPTYING 8 0.0006
618 DRUG DOSE OMISSION 97 0.0006
619 DRUG ADMINISTRATION ERROR 18 0.0006
620 EUPHORIC MOOD 6 0.0006
621 TOOTH DISORDER 13 0.0006
622 HAEMOGLOBIN DECREASED 60 0.0006
623 EMOTIONAL DISORDER 18 0.0006
624 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
625 DISORIENTATION 23 0.0006
626 EJECTION FRACTION DECREASED 9 0.0006
627 LOCALISED INFECTION 14 0.0006
628 MYOPATHY 5 0.0006
629 NASAL CONGESTION 34 0.0006
630 HERPES ZOSTER 33 0.0006
631 COORDINATION ABNORMAL 8 0.0006
632 ACUTE RESPIRATORY FAILURE 11 0.0006
633 THROMBOSIS 46 0.0006
634 LOSS OF CONSCIOUSNESS 73 0.0006
635 GROIN PAIN 5 0.0006
636 GRIP STRENGTH DECREASED 5 0.0006
637 SUDDEN DEATH 6 0.0006
638 HYPERCALCAEMIA 7 0.0006
639 RESPIRATORY TRACT CONGESTION 9 0.0006
640 RENAL PAIN 6 0.0006
641 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
642 BRADYCARDIA 30 0.0006
643 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
644 HEAD DISCOMFORT 10 0.0006
645 HEPATIC FAILURE 17 0.0006
646 CHILLS 66 0.0006
647 BREAST PAIN 6 0.0006
648 PLEURAL EFFUSION 34 0.0006
649 HYPOGLYCAEMIA 27 0.0006
650 ANAL INCONTINENCE 5 0.0006
651 NERVOUSNESS 29 0.0006
652 PARAESTHESIA ORAL 8 0.0006
653 RASH PRURITIC 30 0.0006
654 AMNESIA 36 0.0006
655 ANOSMIA 8 0.0006
656 LEUKOCYTOSIS 10 0.0006
657 OESOPHAGITIS 6 0.0005
658 NIGHTMARE 19 0.0005
659 HYPERGLYCAEMIA 20 0.0005
660 METASTASES TO BONE 9 0.0005
661 ASPIRATION 6 0.0005
662 DRY SKIN 73 0.0005
663 SKIN LESION 15 0.0005
664 RESTLESSNESS 20 0.0005
665 PRODUCT PHYSICAL ISSUE 11 0.0005
666 SKIN BURNING SENSATION 39 0.0005
667 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
668 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
669 BLOOD PRESSURE DECREASED 36 0.0005
670 HEART RATE DECREASED 19 0.0005
671 HYPERTENSIVE CRISIS 6 0.0005
672 LYMPHADENOPATHY 19 0.0005
673 WOUND 15 0.0005
674 MALNUTRITION 6 0.0005
675 TREMOR 89 0.0005
676 DEFORMITY 5 0.0005
677 INTESTINAL PERFORATION 6 0.0005
678 BONE LOSS 8 0.0005
679 CONFUSIONAL STATE 86 0.0005
680 TARDIVE DYSKINESIA 15 0.0005
681 MEMORY IMPAIRMENT 73 0.0005
682 TOOTH LOSS 11 0.0005
683 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
684 DERMATITIS CONTACT 6 0.0005
685 NAUSEA 415 0.0005
686 INFLAMMATION 27 0.0005
687 MULTI-ORGAN FAILURE 9 0.0005
688 CATARACT 31 0.0005
689 METASTASES TO LUNG 6 0.0005
690 DELIRIUM 18 0.0005
691 PRODUCT TASTE ABNORMAL 7 0.0005
692 UVEITIS 7 0.0005
693 DIZZINESS POSTURAL 5 0.0005
694 PRODUCT QUALITY ISSUE 70 0.0005
695 HYPERKALAEMIA 18 0.0005
696 ABDOMINAL PAIN 119 0.0005
697 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
698 HEADACHE 319 0.0005
699 HEPATOMEGALY 5 0.0005
700 PRODUCT PRESCRIBING ISSUE 11 0.0005
701 CHOLECYSTITIS 6 0.0005
702 INABILITY TO AFFORD MEDICATION 5 0.0005
703 PNEUMONIA 163 0.0005
704 FEELING COLD 14 0.0005
705 HUNGER 7 0.0005
706 RASH GENERALISED 13 0.0005
707 RESPIRATORY DISORDER 15 0.0005
708 PRESCRIBED UNDERDOSE 10 0.0005
709 MASS 7 0.0005
710 BRAIN INJURY 5 0.0005
711 HEPATITIS C 6 0.0005
712 SPEECH DISORDER 26 0.0005
713 INJECTION SITE PRURITUS 33 0.0005
714 MOTOR DYSFUNCTION 5 0.0005
715 CONVULSION 28 0.0005
716 WHEEZING 29 0.0005
717 SUBDURAL HAEMATOMA 7 0.0005
718 INJECTION SITE RASH 15 0.0005
719 INJECTION SITE BRUISING 39 0.0005
720 INJECTION SITE HAEMORRHAGE 39 0.0005
721 MOBILITY DECREASED 35 0.0005
722 INJECTION SITE MASS 18 0.0005
723 SKIN EXFOLIATION 41 0.0005
724 VISUAL IMPAIRMENT 60 0.0005
725 DEVICE MALFUNCTION 34 0.0005
726 DISEASE RECURRENCE 23 0.0005
727 BACTERIAL INFECTION 9 0.0005
728 HYPOKINESIA 7 0.0005
729 DISTURBANCE IN ATTENTION 26 0.0005
730 FREQUENT BOWEL MOVEMENTS 13 0.0005
731 EYE DISCHARGE 5 0.0005
732 COMPLETED SUICIDE 40 0.0005
733 HAEMORRHAGE 50 0.0005
734 DRUG-INDUCED LIVER INJURY 15 0.0005
735 ASTHMA 54 0.0005
736 SWELLING FACE 31 0.0005
737 INJECTION SITE PAIN 146 0.0005
738 PERICARDIAL EFFUSION 11 0.0005
739 RASH 207 0.0005
740 ABDOMINAL PAIN LOWER 12 0.0005
741 CANDIDA INFECTION 8 0.0005
742 PROTEINURIA 9 0.0005
743 ANGER 16 0.0005
744 DRUG INTERACTION 75 0.0005
745 SWELLING 44 0.0005
746 INTRAOCULAR PRESSURE INCREASED 6 0.0005
747 GASTROINTESTINAL DISORDER 42 0.0005
748 HAEMORRHAGE INTRACRANIAL 7 0.0005
749 DYSKINESIA 19 0.0005
750 MALAISE 205 0.0005
751 GASTRIC DISORDER 16 0.0005
752 IRRITABILITY 28 0.0005
753 ARRHYTHMIA 22 0.0005
754 SURGERY 27 0.0005
755 CARDIAC DISORDER 43 0.0005
756 NEPHROLITHIASIS 21 0.0005
757 TREATMENT NONCOMPLIANCE 25 0.0005
758 INCORRECT PRODUCT STORAGE 6 0.0005
759 INTENTIONAL DOSE OMISSION 13 0.0005
760 DISABILITY 9 0.0005
761 CARDIO-RESPIRATORY ARREST 19 0.0005
762 PANCREATITIS 24 0.0005
763 APPLICATION SITE PAIN 10 0.0005
764 PRODUCT SUBSTITUTION ISSUE 26 0.0005
765 DELUSION 7 0.0005
766 INFLUENZA LIKE ILLNESS 37 0.0004
767 COLITIS 17 0.0004
768 VOMITING 210 0.0004
769 PRODUCT DOSE OMISSION 29 0.0004
770 HYPOACUSIS 19 0.0004
771 APPLICATION SITE PRURITUS 10 0.0004
772 HEPATIC ENZYME INCREASED 30 0.0004
773 PRODUCTIVE COUGH 21 0.0004
774 ABSCESS 7 0.0004
775 METABOLIC ACIDOSIS 14 0.0004
776 APPLICATION SITE RASH 6 0.0004
777 MUSCLE TWITCHING 10 0.0004
778 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
779 BLOOD POTASSIUM INCREASED 7 0.0004
780 INTENTIONAL DRUG MISUSE 9 0.0004
781 SEPSIS 48 0.0004
782 ELECTROLYTE IMBALANCE 5 0.0004
783 HYPOPHAGIA 11 0.0004
784 UNRESPONSIVE TO STIMULI 11 0.0004
785 EYE DISORDER 14 0.0004
786 BLINDNESS UNILATERAL 6 0.0004
787 PHOTOPHOBIA 8 0.0004
788 DYSARTHRIA 16 0.0004
789 HALLUCINATION 32 0.0004
790 COVID-19 PNEUMONIA 5 0.0004
791 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
792 VISUAL ACUITY REDUCED 14 0.0004
793 INFLUENZA 47 0.0004
794 BACTERAEMIA 5 0.0004
795 IMPAIRED WORK ABILITY 9 0.0004
796 URINARY RETENTION 14 0.0004
797 MULTIPLE SCLEROSIS 20 0.0004
798 MUSCLE RIGIDITY 5 0.0004
799 PULMONARY FIBROSIS 8 0.0004
800 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
801 POST PROCEDURAL COMPLICATION 8 0.0004
802 BONE DENSITY DECREASED 13 0.0004
803 PLATELET COUNT DECREASED 44 0.0004
804 ADVERSE EVENT 38 0.0004
805 GASTROENTERITIS 6 0.0004
806 CIRCULATORY COLLAPSE 7 0.0004
807 SLEEP DISORDER 29 0.0004
808 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
809 JAUNDICE 11 0.0004
810 PAIN OF SKIN 11 0.0004
811 PARANOIA 7 0.0004
812 CYST 5 0.0004
813 CARDIAC ARREST 33 0.0004
814 HYPOTENSION 80 0.0004
815 CHROMATURIA 9 0.0004
816 INCORRECT DOSE ADMINISTERED 91 0.0004
817 COLD SWEAT 7 0.0004
818 PROCEDURAL PAIN 11 0.0004
819 BLOOD GLUCOSE DECREASED 19 0.0004
820 PRODUCT USE IN UNAPPROVED INDICATION 98 0.0004
821 AGITATION 29 0.0004
822 ERYTHEMA 81 0.0004
823 THROMBOCYTOPENIA 44 0.0004
824 DRUG DISPENSING ERROR 6 0.0004
825 ISCHAEMIC STROKE 7 0.0004
826 MYDRIASIS 5 0.0004
827 THERAPY CESSATION 20 0.0004
828 GAIT INABILITY 13 0.0004
829 INJECTION SITE WARMTH 8 0.0004
830 INJECTION SITE ERYTHEMA 48 0.0004
831 INJECTION SITE INDURATION 5 0.0004
832 PELVIC PAIN 7 0.0004
833 DIPLOPIA 10 0.0004
834 ANGIOEDEMA 17 0.0004
835 DRUG INTOLERANCE 37 0.0004
836 TACHYCARDIA 34 0.0004
837 HAND DEFORMITY 5 0.0004
838 OCULAR HYPERAEMIA 18 0.0004
839 BLOOD GLUCOSE ABNORMAL 7 0.0004
840 PRODUCT USE ISSUE 71 0.0004
841 URTICARIA 63 0.0004
842 EYE HAEMORRHAGE 5 0.0004
843 INTESTINAL OBSTRUCTION 14 0.0004
844 CEREBRAL INFARCTION 9 0.0004
845 DEVICE ISSUE 33 0.0004
846 MENTAL DISORDER 16 0.0004
847 HYPERSENSITIVITY 67 0.0004
848 VIRAL INFECTION 12 0.0004
849 LEUKOPENIA 18 0.0004
850 ILLNESS 37 0.0004
851 DEMENTIA 10 0.0004
852 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
853 EYE PRURITUS 12 0.0004
854 RASH PAPULAR 8 0.0004
855 KIDNEY INFECTION 7 0.0004
856 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
857 RESPIRATORY FAILURE 26 0.0004
858 PANCREATITIS ACUTE 8 0.0004
859 BLOOD GLUCOSE INCREASED 67 0.0004
860 HAEMATEMESIS 9 0.0004
861 COVID-19 62 0.0004
862 ERECTILE DYSFUNCTION 9 0.0004
863 LUNG DISORDER 17 0.0003
864 MIGRAINE 33 0.0003
865 RESPIRATORY TRACT INFECTION 9 0.0003
866 INJECTION SITE HAEMATOMA 5 0.0003
867 MUCOSAL INFLAMMATION 9 0.0003
868 NEEDLE ISSUE 10 0.0003
869 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
870 APATHY 5 0.0003
871 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
872 ASCITES 10 0.0003
873 DRUG ERUPTION 6 0.0003
874 EAR INFECTION 9 0.0003
875 DRUG INEFFECTIVE 445 0.0003
876 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
877 COLON CANCER 5 0.0003
878 CEREBRAL HAEMORRHAGE 12 0.0003
879 DERMATITIS 7 0.0003
880 BLOOD PRESSURE FLUCTUATION 8 0.0003
881 BLOOD BILIRUBIN INCREASED 9 0.0003
882 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
883 CONDITION AGGRAVATED 101 0.0003
884 HALLUCINATION, VISUAL 7 0.0003
885 DRUG WITHDRAWAL SYNDROME 29 0.0003
886 DEVICE FAILURE 5 0.0003
887 INSURANCE ISSUE 5 0.0003
888 DEVICE RELATED INFECTION 5 0.0003
889 INFECTION 47 0.0003
890 LYMPHOMA 5 0.0003
891 LUNG INFECTION 5 0.0003
892 ACUTE MYELOID LEUKAEMIA 5 0.0003
893 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
894 NERVOUS SYSTEM DISORDER 10 0.0003
895 SUICIDAL IDEATION 29 0.0003
896 NEOPLASM PROGRESSION 11 0.0003
897 LIVER DISORDER 14 0.0003
898 CARDIOVASCULAR DISORDER 8 0.0003
899 HYPOXIA 11 0.0003
900 PANCREATIC CARCINOMA 9 0.0003
901 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
902 ECZEMA 16 0.0003
903 APPLICATION SITE ERYTHEMA 8 0.0003
904 OFF LABEL USE 267 0.0003
905 PANCYTOPENIA 17 0.0003
906 PRODUCT DOSE OMISSION ISSUE 89 0.0003
907 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
908 FEEDING DISORDER 6 0.0003
909 BLINDNESS 12 0.0003
910 MOOD ALTERED 8 0.0003
911 RASH ERYTHEMATOUS 14 0.0003
912 MULTIPLE SCLEROSIS RELAPSE 20 0.0003
913 COLITIS ULCERATIVE 13 0.0003
914 DEVICE DEFECTIVE 5 0.0003
915 CARDIAC FAILURE 23 0.0003
916 OXYGEN SATURATION DECREASED 16 0.0003
917 LYMPHOCYTE COUNT DECREASED 5 0.0003
918 EXTRAPYRAMIDAL DISORDER 7 0.0003
919 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
920 BREAST CANCER 26 0.0003
921 DISCOMFORT 17 0.0003
922 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
923 PYREXIA 96 0.0003
924 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
925 INJECTION SITE REACTION 19 0.0003
926 SEPTIC SHOCK 12 0.0003
927 PANIC ATTACK 10 0.0003
928 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
929 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
930 PSYCHOTIC DISORDER 8 0.0003
931 TRANSAMINASES INCREASED 6 0.0003
932 PRODUCT AVAILABILITY ISSUE 6 0.0003
933 ILL-DEFINED DISORDER 16 0.0003
934 WITHDRAWAL SYNDROME 11 0.0003
935 INJECTION SITE SWELLING 20 0.0003
936 SHOCK 6 0.0003
937 PALLOR 7 0.0003
938 RESPIRATORY DISTRESS 7 0.0003
939 MEDICATION ERROR 14 0.0003
940 THERAPEUTIC RESPONSE DECREASED 15 0.0002
941 ADVERSE DRUG REACTION 22 0.0002
942 OSTEONECROSIS 8 0.0002
943 NEOPLASM MALIGNANT 16 0.0002
944 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
945 PLASMA CELL MYELOMA 9 0.0002
946 DISEASE PROGRESSION 27 0.0002
947 THERAPY INTERRUPTED 16 0.0002
948 C-REACTIVE PROTEIN INCREASED 8 0.0002
949 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
950 TOXICITY TO VARIOUS AGENTS 36 0.0002
951 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
952 FEBRILE NEUTROPENIA 14 0.0002
953 INJECTION SITE URTICARIA 5 0.0002
954 LIVER INJURY 5 0.0002
955 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
956 THERAPY NON-RESPONDER 9 0.0002
957 ANAPHYLACTIC REACTION 11 0.0002
958 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
959 ACNE 15 0.0002
960 EXTRA DOSE ADMINISTERED 8 0.0002
961 NEUTROPHIL COUNT DECREASED 8 0.0002
962 PRODUCT ADHESION ISSUE 7 0.0002
963 LUNG NEOPLASM MALIGNANT 8 0.0002
964 ACCIDENTAL OVERDOSE 7 0.0002
965 NEUTROPENIA 26 0.0002
966 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
967 MOOD SWINGS 6 0.0002
968 SEIZURE 21 0.0002
969 INFUSION RELATED REACTION 12 0.0002
970 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
971 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
972 RHABDOMYOLYSIS 7 0.0002
973 DEATH 143 0.0002
974 NO ADVERSE EVENT 30 0.0002
975 PROSTATE CANCER 13 0.0002
976 DEVICE LEAKAGE 7 0.0002
977 DEVICE DISLOCATION 7 0.0002
978 AGGRESSION 8 0.0002
979 ABNORMAL BEHAVIOUR 6 0.0002
980 COGNITIVE DISORDER 7 0.0001
981 DEVICE BREAKAGE 6 0.0001
982 RENAL CANCER 7 0.0001
983 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
984 HOSPITALISATION 21 0.0001
985 OVERDOSE 29 0.0001
986 DERMATITIS ATOPIC 7 0.0001
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
988 SUICIDE ATTEMPT 7 0.0001
989 INTERSTITIAL LUNG DISEASE 5 0.0001
990 TREATMENT FAILURE 7 0.0001
991 PRODUCT STORAGE ERROR 7 0.0001
992 DRUG DOSE OMISSION BY DEVICE 5 0.0001
993 DRUG DEPENDENCE 9 0.0001